National Institute of Allergy and Infectious Diseases
NIAID Home Health & Science Research Funding Research News & Events Labs at NIAID About NIAID

Resources for Researchers
 AIDS Therapies Resource Guide
 Bioinformatics Resource Centers
 Centers for AIDS Research (CFAR)
 Clinical Proteomics Centers
 Clinical Research Toolkit
 DAIDS Clinical Research Policies
 DMID Resources for Researchers
 DMID Clinical Research Policies
 HIV/AIDS Specimen Repository
 Influenza Centers of Excellence (CEIRS)
 Genome Sequencing Centers
 Pathogen Functional Genomics Resource Center
 Proteomics Research Centers
 Rabbit in Immunology and Infectious Disease Research
 Regional Centers of Excellence
 Structural Genomics Centers for Infectious Diseases
 Systems Biology for Infectious Diseases Research
 Vaccine and Treatment Evaluation Units


Resources for Researchers

Non-Obese Diabetic (NOD) Mouse BAC Library

The Wellcome Trust Sanger Institute (Cambridge, United Kingdom) recently released to the scientific community a Non-Obese Diabetic (NOD) mouse BAC library containing 240,000 clones obtained from the Diabetes and Inflammation Laboratory (Cambridge, United Kingdom).

The NOD mouse, which spontaneously develops type 1 diabetes, is a valuable animal model that is used extensively in research exploring the etiology, prevention, and treatment of this disease. It is a vital research tool for testing promising prevention and treatment strategies at the preclinical level.

The Sanger Institute sequenced the complete NOD BAC library and used this resource to complete a physical map of the BAC clones. As a next step, they plan to sequence the 200,000 clones from the Pieter de Jong library (Children's Hospital, Oakland CA). These sequences will be aligned with those from the most recent version of the normal C57B1/6 (B6) mouse strain (a non-diabetic mouse strain) in an effort to identify single nucleotide differences between NOD mouse clone end sequences and the B6 mouse genome. Investigators at the Sanger Institute will use this sequencing information to identify and map candidate genes. Such information will guide efforts to isolate genes that contribute to the development of type 1 diabetes in humans.

This research was conducted as part of the Immune Tolerance Network, which is jointly funded by the National Institute of Allergy and Infectious Diseases, the National Institute of Diabetes, Digestive, and Kidney Disorders (both part of the National Institutes of Health) and the Juvenile Diabetes Research Foundation.

back to top